Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, par value $0.005 per share
-
Shares outstanding
-
110,002,045
-
Total 13F shares
-
409,206
-
Share change
-
+54,202
-
Total reported value
-
$982,076
-
Price per share
-
$2.40
-
Number of holders
-
22
-
Value change
-
+$130,770
-
Number of buys
-
7
-
Number of sells
-
3
Institutional Holders of Ernexa Therapeutics Inc. - Common Stock, par value $0.005 per share (ERNA) as of Q1 2024
As of 31 Mar 2024,
Ernexa Therapeutics Inc. - Common Stock, par value $0.005 per share (ERNA) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
409,206 shares.
The largest 10 holders included
Cypress Point Wealth Management, LLC, Naviter Wealth, LLC, Sippican Capital Advisors, Corient Private Wealth LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., Avidian Wealth Solutions, LLC, CITADEL ADVISORS LLC, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
22
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.